GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
Candel Therapeutics to Participate in the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference
Why BioRestorative Therapies Stock Is Moving Higher Thursday
Pancreatic Cancer on the Rise: How Biotech Firms Are Developing Groundbreaking Treatments
Express News | Candel Therapeutics to Join Russell 3000® Index
Candel Therapeutics to Join Russell 3000 Index
Retail Investors Among Candel Therapeutics, Inc.'s (NASDAQ:CADL) Largest Stockholders and Were Hit After Last Week's 20% Price Drop
12 Health Care Stocks Moving In Monday's After-Market Session
Candel Therapeutics shares rose 3.4% after the U.S. Food and Drug Administration provided an orphan drug label for the company's glioma treatment
Candel Therapeutics shares rose 3.4% after the U.S. Food and Drug Administration provided an orphan drug label for the company's glioma treatment
Express News | Candel Therapeutics Shares up 3.4% After FDA Grants Orphan Drug Tag for Co's Glioma Treatment
Market-Moving News for May 30th
Candel Therapeutics Gets FDA's Orphan-Drug Status for Glioma Treatment
Candel Therapeutics Shares Are Trading Higher After the FDA Granted Orphan Drug Designation to CAN-3110.
Express News | FDA Grants Orphan Drug Designation for Can-3110 for the Treatment of Recurrent High-Grade Glioma
Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why
12 Health Care Stocks Moving In Monday's Pre-Market Session
Express News | Candel Therapeutics Shares Down 21%
Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Candel Therapeutics shares rose 19.3% in the premarket due to good mid-term trial data for lung cancer treatment
Candel Therapeutics shares rose 19.3% in the premarket due to good mid-term trial data for lung cancer treatment
Express News | Candel Therapeutics Shares up 19.3% Premarket on Positive Mid-Stage Trial Data for Lung Cancer Treatment